X

Health Care

Infographic : Brooks Labrotories (NSE : BROOKS) | Q4FY22 Results Released! | Revenue UP 94.55% YoY

Brooks Laboratories Ltd is a pharmaceutical contract manufacturing company. The company has manufacturing facilities in Baddi Himachal Pradesh and Vadodara…

Infographic : Brooks Labrotories (NSE : BROOKS) | Q1 Results Released! | Revenue DOWN 23.21% YoY

Brooks Laboratories Ltd is a pharmaceutical contract manufacturing company. The company has manufacturing facilities in Baddi Himachal Pradesh and Vadodara…

JB Chemicals & Pharmaceuticals Limited Q2 FY23 Earnings Conference Call Insights

Key highlights from JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) Q2 FY23 Earnings Concall Management Update: [00:06:28] JBCHEPHARM said that in…

Biocon Limited Q2 FY23 Earnings Conference Call Insights

Key highlights from Biocon Limited (BIOCON) Q2 FY23 Earnings Concall Q&A Highlights: [00:23:49] Prakash Agarwal of Axis Capital asked about…

IOL Chemicals and Pharmaceuticals Limited (IOLCP) Q2 FY23 Earnings Concall Transcript

IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP) Q2 FY23 Earnings Concall dated Nov. 15, 2022 Corporate Participants: Sanjay Chaturvedi -- Executive Director and…

FDC Ltd (FDC) Q2 FY23 Earnings Concall Transcript

FDC Ltd (NSE:FDC) Q2 FY23 Earnings Concall dated Nov. 15, 2022 Corporate Participants: Varsharani Katre -- Company Secretary and Compliance Officer Sanjay Jain -- Chief Financial…

Aarti Industries Ltd (AARTIIND) Q2 FY23 Earnings Concall Transcript

Aarti Industries Ltd (NSE:AARTIIND) Q2 FY23 Earnings Concall dated Nov. 15, 2022 Corporate Participants: Rajendra V. Gogri -- Chairman and…

Aurobindo Pharma Q2FY23; 41% Fall in Profits

Aurobindo Pharma Ltd.‘s revenue in Q2FY23 fell 3% to ₹ 5,739 crores. Consolidated Profit came at ₹ 409 crores showcasing…

Biocon Limited (BIOCON) Q2 FY23 Earnings Concall Transcript

Biocon Limited (NSE: BIOCON) Q2 FY23 Earnings Concall dated Nov. 14, 2022 Corporate Participants: Saurabh Paliwal -- Head, Investor Relations…

JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) Q2 FY23 Earnings Concall Transcript

JB Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Q2 FY23 Earnings Concall dated Nov. 14, 2022 Corporate Participants: Jason D'Souza -- Vice President of Investor Relations…